Type 2 Diabetes (Metabolic Disorder) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

Pages: 1416 Published: October 31, 2021 Report Code: GMDGDHC13118IDB

Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin functioning, glucose is concentrated in the blood leading to elevated levels and hence causing type 2 diabetes. Symptoms include fatigue, weight issues, vision deficits, and various other effects. Risk factors include family history, age, obesity, physical inactivity, and high blood pressure. This condition is handled by lifestyle alterations and regular medications.

The type 2 diabetes drugs in development market research report provides comprehensive information on the therapeutics under development for type 2 diabetes, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for type 2 diabetes and features dormant and discontinued projects.

What are the key targets in type 2 diabetes pipeline products market?

The key targets in the type 2 diabetes pipeline products market are glucagon like peptide 1 receptor, insulin receptor, dipeptidyl peptidase 4, adenosine monophosphate activated protein kinase, glucagon receptor, glucagon receptor, gastric inhibitory polypeptide receptor, glucokinase, peroxisome proliferator activated receptor gamma, and others.

Type 2 Diabetes Pipeline Products Analysis Market by Targets

Type 2 Diabetes Pipeline Products Analysis Market by Targets

For more target insights, download a free report sample

What are the key mechanisms of action in the type 2 diabetes pipeline products market?

The key mechanisms of action in the type 2 diabetes pipeline products market are glucagon like peptide 1 receptor agonist, insulin receptor agonist, dipeptidyl peptidase 4 inhibitor, sodium/glucose cotransporter 2 inhibitor, adenosine monophosphate activated protein kinase activator, glucagon receptor agonist, free fatty acid receptor 1 agonist, glucokinase activator, gastric inhibitory polypeptide receptor agonist, glucagon like peptide 1 activator, and others.

Type 2 Diabetes Pipeline Products Market Analysis by Mechanism of Actions

Type 2 Diabetes Pipeline Products Market Analysis by Mechanism of Actions

For more mechanism of actions insights, download a free report sample

What are the key routes of administration in the Type 2 diabetes pipeline products market?

The key routes of administration in the Type 2 diabetes pipeline products market are oral, subcutaneous, parenteral, intravenous, transdermal, buccal, inhalational, sublingual, intraarticular, intracardiac, and others.

Type 2 Diabetes Pipeline Products Market Analysis by Routes of Administration

Type 2 Diabetes Pipeline Products Market Analysis by Routes of Administration

For more routes of administration insights, download a free report sample

What are the different molecule types in the type 2 diabetes pipeline products market?

The different molecule types in the type 2 diabetes pipeline products market are small molecule, recombinant peptide, synthetic peptide, peptide, fusion protein, recombinant protein, biologic, monoclonal antibody, cell therapy, gene therapy, and others.

Type 2 diabetes Pipeline Products Market Analysis by Molecule Type

Type 2 diabetes Pipeline Products Market Analysis by Molecule Type

To know more about molecule types, download a free report sample

Which are the major companies in the type 2 diabetes pipeline products market?

The major companies in the type 2 diabetes pipeline products market are Eli Lilly and Co, Novo Nordisk AS, Merck & Co Inc, Tonghua Dongbao Pharmaceutical Co Ltd, Chong Kun Dang Pharmaceutical Corp, Sihuan Pharmaceutical Holdings Group Ltd, AstraZeneca Plc, Diasome Pharmaceuticals Inc, Intarcia Therapeutics Inc, and Thermalin Inc, Adocia SAS.

Type 2 Diabetes Pipeline Products Market Analysis by Companies

Type 2 Diabetes Pipeline Products Market Analysis by Companies

To know more about major companies, download a free report sample

Market Report Scope

Key targets Glucagon Like Peptide 1 Receptor, Insulin Receptor, Dipeptidyl Peptidase 4, Adenosine Monophosphate Activated Protein Kinase, Glucagon Receptor, Glucagon Receptor, Gastric Inhibitory Polypeptide Receptor, Glucokinase, Peroxisome Proliferator Activated Receptor Gamma, and Others
Key mechanism of action Glucagon Like Peptide 1 Receptor Agonist, Insulin Receptor Agonist, Dipeptidyl Peptidase 4 Inhibitor, Sodium/Glucose Cotransporter 2 Inhibitor, Adenosine Monophosphate Activated Protein Kinase Activator, Glucagon Receptor Agonist, Free Fatty Acid Receptor 1 Agonist, Glucokinase Activator, Gastric Inhibitory Polypeptide Receptor Agonist, Glucagon Like Peptide 1 Activator, and Others
Key routes of administration Oral, Subcutaneous, Parenteral, Intravenous, Transdermal, Buccal, Inhalational, Sublingual, Intraarticular, Intracardiac, and Others
Molecule type Small Molecule, Recombinant Peptide, Synthetic Peptide, Peptide, Fusion Protein, Recombinant Protein, Biologic, Monoclonal Antibody, Cell Therapy, Gene Therapy, and Others
Major companies Eli Lilly and Co, Novo Nordisk AS, Merck & Co Inc, Tonghua Dongbao Pharmaceutical Co Ltd, Chong Kun Dang Pharmaceutical Corp, Sihuan Pharmaceutical Holdings Group Ltd, AstraZeneca Plc, Diasome Pharmaceuticals Inc, Intarcia Therapeutics Inc, and Thermalin Inc, Adocia SAS

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Type 2 Diabetes (Metabolic Disorders).
  • The pipeline guide reviews pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Type 2 Diabetes (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Type 2 Diabetes (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews the latest news related to pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders)

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Type 2 Diabetes (Metabolic Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Type 2 Diabetes (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.

Key Players

3SBio Inc

Abarceo Pharma AB

Adare Pharma Solutions

Addpharma Inc

ADM Therapeutics

Adocia SAS

Aerami Therapeutics Inc

Afimmune Biopharma Ltd

Agentix Corp

AgeX Therapeutics Inc

Aju Pharm Co Ltd

Akero Therapeutics Inc

Akston Biosciences Corp

Algiax Pharmaceuticals GmbH

Alms Therapeutics

Alnylam Pharmaceuticals Inc

AlphaMab Co Ltd

Altimmune Inc

AltrixBio Inc

Amide Technologies Inc

AmideBio LLC

Anagenesis Biotechnologies SAS

Ananda Scientific Inc

Anji Pharmaceuticals Inc

AnyGen Co Ltd

Apcegen Technologies Pvt Ltd

Aphios Corp

Apoglyx AB

APT Therapeutics Inc

Aptamer Sciences Inc

AptamiR Therapeutics Inc

Arecor Therapeutics Plc

Ariddad Therapeutics SL

Arkay Therapeutics LLC

Artery Therapeutics Inc

AsiaBiome

Astellas Pharma Inc

AstraZeneca Plc

Atrogi AB

Autotac Bio Inc

Avolynt Inc

Beijing Eastern Biotech Co Ltd

Beijing SL Pharmaceutical Co Ltd

Belite Bio Inc

Betagenon AB

Betta Pharmaceuticals Co Ltd

Biocon Ltd

BioEos Ltd

Biogenomics Ltd

BioKier Inc

BioLingus AG

Biomea Fusion Inc

BioRestorative Therapies Inc

Biotts SA

Biozeus Pharmaceutical SA

Boehringer Ingelheim International GmbH

Bopin (Shanghai) Biomedical Technology Co Ltd

Boryung Pharmaceutical Co Ltd

Boston Therapeutics Inc

Braasch Biotech LLC

BrightGene Bio-Medical Technology Co Ltd

Buto Biopharma Inc

C4X Discovery Holdings Plc

Cadila Healthcare Ltd

Caelus Health

Caldan Therapeutics Ltd

CAR-T (Shanghai) Biotechnology Co Ltd

Carlina Technologies SAS

Carmot Therapeutics Inc

Cellix Bio Pvt Ltd

Celon Pharma SA

Centaurus Therapeutics Inc

Center Laboratories Inc

CGeneTech (Suzhou China) Co Ltd

Chain Biotechnology Ltd

Chengdu Di’ao Pharmaceutical Group Co Ltd

Chengdu Easton Biopharmaceuticals Co Ltd

Chengdu Shengdi Medical Company Co Ltd

Chong Kun Dang Pharmaceutical Corp

Chongqing Chenan BioPharm Co Ltd

Chongquing Conquer Pharmaceutical Co Ltd

Cinnagen Co

CMG Pharmaceutical Co Ltd

CohBar Inc

Coherus BioSciences Inc

Concenter BioPharma Silkim Ltd

ConjuChem LLC

CRISPR Therapeutics AG

Cryno LLC

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co Ltd

D&D Pharmatech Co Ltd

Daewon Pharmaceutical Co Ltd

Daewoong Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Delpor Inc

Diabetology (Products) Ltd

Diamyd Medical AB

Diapin Therapeutics LLC

Diasome Pharmaceuticals Inc

DiscoveryBiomed Inc

DNJ Pharma Inc

DNX Biopharmaceuticals Inc

Dong Wha Pharma Co Ltd

Dong-A Socio Holdings Co Ltd

Dong-A ST Co Ltd

EastGate Pharmaceuticals Inc

Eccogene (Shanghai) Co Ltd

Egy-Nano Pharma LP

Elevian Inc

Eli Lilly and Co

Emerald Organic Products Inc

Emmaus Life Sciences Inc

Empros Pharma AB

EncuraGen Inc

Energenesis Biomedical Co Ltd

Enesi Pharma Ltd

Enteris BioPharma Inc

Enzene Biosciences Ltd

Enzo Biochem Inc

Epichem Pty Ltd

Eternygen GmbH

Evotec SE

F. Hoffmann-La Roche Ltd

Fairbanks Pharmaceuticals Inc

Fochon Pharmaceutical Ltd

Forkhead BioTherapeutics Inc

FortuneRock (China) Ltd

Fujian Haixi New Medicine Creation Co Ltd

Gan & Lee Pharmaceuticals Co Ltd

Generex Biotechnology Corp

Genexine Inc

Genovate Biotechnology Co LTD

Genprex Inc

Geropharm

GL Pharm Tech Corp

Glaceum Inc

Glucox Biotech AB

Glyscend Inc

Gmax Biopharm LLC

Guangdong Zhongsheng Pharmaceutical Co Ltd

Guangzhou Magpie Pharmaceutical Co Ltd

Gubra ApS

Gusto Global LLC

Hangzhou East China Pharmaceutical Group Co Ltd

Hangzhou Jiuyuan Gene Engineering Co Ltd

Hanmi Pharmaceuticals Co Ltd

HCW Biologics Inc

HEC Pharma Co Ltd

Hefei Industrial Pharmaceutical Institute Co Ltd

Hengrui Therapeutics Inc

HighTide Therapeutics Inc

HK inno.N Corp

Housey Pharmaceutical Research Laboratories LLC

Hua Medicine Shanghai Ltd

Huadong Medicine Co Ltd

Hualan Biological Engineering Inc

Hyundai Pharma Co Ltd

Ildong Pharmaceutical Co Ltd

Imagine Pharma LLC

Immunwork Inc

Immupharma Plc

Immuron Ltd

Impetis Biosciences Ltd

Inflammasome Therapeutics Inc

Innovimmune Biotherapeutics Inc

Inspyr Therapeutics Inc

Intarcia Therapeutics Inc

Integral Molecular Inc

Ionis Pharmaceuticals Inc

Japan Tobacco Inc

Jeil Pharmaceutical Co Ltd

Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd

Jiangsu Hansoh Pharmaceutical Group Co Ltd

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Lianhuan Pharmaceutical Co Ltd

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Jiangsu T-mab BioPharma Co Ltd

Johnson & Johnson

Kadimastem Ltd

Kaneq Bioscience Ltd

Karyo Biologics LLC

KB Biomed Inc

Klotho Therapeutics Inc

Kolmar Korea Co Ltd

Kriya Therapeutics Inc

Kyung Dong Co Ltd

Laboratorios Silanes SA de CV

Lannett Co Inc

Lanzhou Institute of Biological Products Co Ltd

Lead Discovery Center GmbH

Lepu Medical Technology (Beijing) Co Ltd

Levim Biotech LLP

Lexicon Pharmaceuticals Inc

LG Chem Ltd

LipimetiX Development Inc

Livzon Pharmaceutical Group Co Ltd

Lixte Biotechnology Holdings Inc

Longevity Biotech Inc

Lotus Pharmaceutical Co Ltd

Luckwel Pharmaceuticals Inc

Luye Pharma Group Ltd

Lyndra Therapeutics Inc.

Mankind Pharma Ltd

MannKind Corp

MD Healthcare Inc

Medesis Pharma SA

Medlab Clinical Ltd

Melior Pharmaceuticals I Inc

Merck & Co Inc

Mesoblast Ltd

Metabolic Solutions Development Company LLC

Metabolys SAS

Metacrine Inc

Metavant Sciences Ltd

MetrioPharm AG

Metynex Pharmaceuticals AB

Mito BioPharm LLC

Mitsubishi Tanabe Pharma Corp

Moogene Medi Inc

Muen (Guangzhou) Biological Technology Co Ltd

MyMD Pharmaceuticals, Inc

Naia Ltd

Navipharm Co Ltd

Neuraly Inc

Neurimmune Holding AG

Neurodon LLC

NGM Biopharmaceuticals Inc

NIMIUM Therapeutics Inc

Novartis AG

NovaTarg Therapeutics Inc

NovMetaPharma Co Ltd

Novo Nordisk AS

NuSirt Biopharma Inc

NutriBand Inc

Oblique Therapeutics AB

OliPass Corporation

Omeros Corp

Oncosimis Biotech Pvt Ltd

OPKO Health Inc

OptiKira LLC

Oramed Pharmaceuticals Inc

Orbsen Therapeutics Ltd

Original BioMedicals Co Ltd

Palatin Technologies Inc

Palisade Bio, Inc

Panorama Researchama Research

Paras Biopharmaceuticals Finland Oy

Park Active Molecules

PegBio Co Ltd

Peptron Inc

Pfizer Inc

PharmaCyte Biotech Inc

Pila Pharma AB

Polus Inc

Poxel SA

Preveceutical Medical Inc

ProLynx LLC

Prometheon Pharma LLC

Protheragen Inc

Prous Institute for Biomedical Research SA

Purzer Pharmaceutical Co Ltd

Qoracle Co Ltd

QuiaPEG Pharmaceuticals AB

Rani Therapeutics LLC

Rebio Technologies Ltd

Regenerative Medical Solutions Inc

Remd Biotherapeutics Inc

Remedium Bio Inc

reMYND NV

Renova Therapeutics Inc

Retinset SL

Rezolute Inc

Ridgeline Therapeutics LLC

Rivus Pharmaceuticals Inc

RosVivo Therapeutics Inc

Samik Pharmaceutical Co Ltd

Samjin Pharm Co Ltd

Sanofi

Sanwa Kagaku Kenkyusho Co Ltd

SBI Pharmaceuticals Co Ltd

ScandiCure AB

Sciwind Biosciences Co Ltd

Scohia Pharma Inc

Senseion Inc

Sensulin LLC

Seres Therapeutics Inc

Serodus ASA

Serpin Pharma LLC

Shaanxi Micot Technology Co Ltd

Shandong Baijidichang Pharmaceutical Co Ltd

Shandong Luye Pharmaceutical Co Ltd

Shanghai Fosun Pharmaceutical (Group) Co Ltd

Shanghai HEP Pharmaceutical Co Ltd

Shanghai Innogen Pharmaceutical Technology Co Ltd

Shanghai Yingli Pharmaceutical Co Ltd

Shenzhen Chipscreen Biosciences Co Ltd

Shenzhen Salubris Pharmaceuticals Co Ltd

Shionogi & Co Ltd

Shouyao Holding Co Ltd

Sichuan Haisco Pharmaceutical Co Ltd

Sihuan Pharmaceutical Holdings Group Ltd

Sino Biopharmaceutical Ltd

Sirona Biochem Corp

SJT Molecular Research SL

SK Chemicals Co Ltd

Sosei Group Corp

Stelis Biopharma Pvt Ltd

Sulfateq BV

Sun Pharmaceutical Industries Ltd

Sveikatal Inc

SymbioCellTech LLC

Synokem Pharmaceuticals Ltd

Taisho Pharmaceutical Holdings Co Ltd

Takeda Pharmaceutical Co Ltd

Techfields Pharma Co Ltd

The Healthy Aging Co

The United Laboratories International Holdings Ltd

Theracos Inc

Thermalin Inc

Tonghua Dongbao Pharmaceutical Co Ltd

Torrent Pharmaceuticals Ltd

Transgene Biotek Ltd

Transira Therapeutics LLC

TTY Biopharm Co Ltd

TWi Biotechnology Inc

Twist Bioscience Corp

UGISense AG

Uni-Bio Science Group Ltd

United Biomedical Inc

USV Pvt Ltd

Valin Technologies Ltd

Versanis Bio Inc

ViaCyte Inc

Viking Therapeutics Inc

VitNovo Inc

Vivus Inc

vTv Therapeutics Inc

Vybion Inc

Wockhardt Ltd

Wuxi Hebang Biotechnology Co Ltd

XERIS Pharmaceuticals Inc

XL-protein GmbH

XOMA Corp

XuanZhu Biological Technology Co Ltd

Yichang Hec Changjiang Pharmaceutical Co Ltd

Youngene Therapeutics Co Ltd

Zealand Pharma AS

Zhejiang Hisun Pharmaceutical Co Ltd

Zhejiang Huayang Pharmaceutical Co Ltd

Zhuhai United Laboratories Co Ltd

Zih Yuan Tang Biotechnology Co Ltd

Zucara Therapeutics Inc

Table of Contents

Table of Contents

Introduction

Type 2 Diabetes – Overview

Type 2 Diabetes – Therapeutics Development

Type 2 Diabetes – Therapeutics Assessment

Type 2 Diabetes – Companies Involved in Therapeutics Development

Type 2 Diabetes – Drug Profiles

Type 2 Diabetes – Dormant Projects

Type 2 Diabetes – Discontinued Products

Type 2 Diabetes – Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Type 2 Diabetes, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Type 2 Diabetes – Pipeline by 3SBio Inc, 2021

Type 2 Diabetes – Pipeline by Abarceo Pharma AB, 2021

Type 2 Diabetes – Pipeline by Adare Pharma Solutions, 2021

Type 2 Diabetes – Pipeline by Addpharma Inc, 2021

Type 2 Diabetes – Pipeline by ADM Therapeutics, 2021

Type 2 Diabetes – Pipeline by Adocia SAS, 2021

Type 2 Diabetes – Pipeline by Aerami Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Afimmune Biopharma Ltd, 2021

Type 2 Diabetes – Pipeline by Agentix Corp, 2021

Type 2 Diabetes – Pipeline by AgeX Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Aju Pharm Co Ltd, 2021

Type 2 Diabetes – Pipeline by Akero Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Akston Biosciences Corp, 2021

Type 2 Diabetes – Pipeline by Algiax Pharmaceuticals GmbH, 2021

Type 2 Diabetes – Pipeline by Alms Therapeutics, 2021

Type 2 Diabetes – Pipeline by Alnylam Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by AlphaMab Co Ltd, 2021

Type 2 Diabetes – Pipeline by Altimmune Inc, 2021

Type 2 Diabetes – Pipeline by AltrixBio Inc, 2021

Type 2 Diabetes – Pipeline by Amide Technologies Inc, 2021

Type 2 Diabetes – Pipeline by AmideBio LLC, 2021

Type 2 Diabetes – Pipeline by Anagenesis Biotechnologies SAS, 2021

Type 2 Diabetes – Pipeline by Ananda Scientific Inc, 2021

Type 2 Diabetes – Pipeline by Anji Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by AnyGen Co Ltd, 2021

Type 2 Diabetes – Pipeline by Apcegen Technologies Pvt Ltd, 2021

Type 2 Diabetes – Pipeline by Aphios Corp, 2021

Type 2 Diabetes – Pipeline by Apoglyx AB, 2021

Type 2 Diabetes – Pipeline by Dong-A ST Co Ltd, 2021

Type 2 Diabetes – Pipeline by EastGate Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by Eccogene (Shanghai) Co Ltd, 2021

Type 2 Diabetes – Pipeline by Egy-Nano Pharma LP, 2021

Type 2 Diabetes – Pipeline by Elevian Inc, 2021

Type 2 Diabetes – Pipeline by Eli Lilly and Co, 2021

Type 2 Diabetes – Pipeline by Emerald Organic Products Inc, 2021

Type 2 Diabetes – Pipeline by Emmaus Life Sciences Inc, 2021

Type 2 Diabetes – Pipeline by Empros Pharma AB, 2021

Type 2 Diabetes – Pipeline by EncuraGen Inc, 2021

Type 2 Diabetes – Pipeline by Energenesis Biomedical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Enesi Pharma Ltd, 2021

Type 2 Diabetes – Pipeline by Enteris BioPharma Inc, 2021

Type 2 Diabetes – Pipeline by Enzene Biosciences Ltd, 2021

Type 2 Diabetes – Pipeline by Enzo Biochem Inc, 2021

Type 2 Diabetes – Pipeline by Epichem Pty Ltd, 2021

Type 2 Diabetes – Pipeline by Eternygen GmbH, 2021

Type 2 Diabetes – Pipeline by Evotec SE, 2021

Type 2 Diabetes – Pipeline by F. Hoffmann-La Roche Ltd, 2021

Type 2 Diabetes – Pipeline by Fairbanks Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by Fochon Pharmaceutical Ltd, 2021

Type 2 Diabetes – Pipeline by Forkhead BioTherapeutics Inc, 2021

Type 2 Diabetes – Pipeline by FortuneRock (China) Ltd, 2021

Type 2 Diabetes – Pipeline by Fujian Haixi New Medicine Creation Co Ltd, 2021

Type 2 Diabetes – Pipeline by Gan & Lee Pharmaceuticals Co Ltd, 2021

Type 2 Diabetes – Pipeline by Generex Biotechnology Corp, 2021

Type 2 Diabetes – Pipeline by Genexine Inc, 2021

Type 2 Diabetes – Pipeline by Genovate Biotechnology Co LTD, 2021

Type 2 Diabetes – Pipeline by Genprex Inc, 2021

Type 2 Diabetes – Pipeline by Geropharm, 2021

Type 2 Diabetes – Pipeline by GL Pharm Tech Corp, 2021

Type 2 Diabetes – Pipeline by Glaceum Inc, 2021

Type 2 Diabetes – Pipeline by Glucox Biotech AB, 2021

Type 2 Diabetes – Pipeline by Glyscend Inc, 2021

Type 2 Diabetes – Pipeline by Gmax Biopharm LLC, 2021

Type 2 Diabetes – Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Gubra ApS, 2021

Type 2 Diabetes – Pipeline by Gusto Global LLC, 2021

Type 2 Diabetes – Pipeline by Hangzhou East China Pharmaceutical Group Co Ltd, 2021

Type 2 Diabetes – Pipeline by Hangzhou Jiuyuan Gene Engineering Co Ltd, 2021

Type 2 Diabetes – Pipeline by Hanmi Pharmaceuticals Co Ltd, 2021

Type 2 Diabetes – Pipeline by HCW Biologics Inc, 2021

Type 2 Diabetes – Pipeline by HEC Pharma Co Ltd, 2021

Type 2 Diabetes – Pipeline by Hefei Industrial Pharmaceutical Institute Co Ltd, 2021

Type 2 Diabetes – Pipeline by Hengrui Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by HighTide Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by HK inno.N Corp, 2021

Type 2 Diabetes – Pipeline by Housey Pharmaceutical Research Laboratories LLC, 2021

Type 2 Diabetes – Pipeline by Hua Medicine Shanghai Ltd, 2021

Type 2 Diabetes – Pipeline by Huadong Medicine Co Ltd, 2021

Type 2 Diabetes – Pipeline by Hualan Biological Engineering Inc, 2021

Type 2 Diabetes – Pipeline by Hyundai Pharma Co Ltd, 2021

Type 2 Diabetes – Pipeline by Ildong Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Imagine Pharma LLC, 2021

Type 2 Diabetes – Pipeline by Immunwork Inc, 2021

Type 2 Diabetes – Pipeline by Immupharma Plc, 2021

Type 2 Diabetes – Pipeline by Immuron Ltd, 2021

Type 2 Diabetes – Pipeline by Impetis Biosciences Ltd, 2021

Type 2 Diabetes – Pipeline by Inflammasome Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Innovimmune Biotherapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Inspyr Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Intarcia Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Integral Molecular Inc, 2021

Type 2 Diabetes – Pipeline by Ionis Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by Japan Tobacco Inc, 2021

Type 2 Diabetes – Pipeline by Jeil Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd, 2021

Type 2 Diabetes – Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021

Type 2 Diabetes – Pipeline by Jiangsu Lianhuan Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Jiangsu T-mab BioPharma Co Ltd, 2021

Type 2 Diabetes – Pipeline by Johnson & Johnson, 2021

Type 2 Diabetes – Pipeline by Kadimastem Ltd, 2021

Type 2 Diabetes – Pipeline by Kaneq Bioscience Ltd, 2021

Type 2 Diabetes – Pipeline by Karyo Biologics LLC, 2021

Type 2 Diabetes – Pipeline by KB Biomed Inc, 2021

Type 2 Diabetes – Pipeline by Klotho Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Kolmar Korea Co Ltd, 2021

Type 2 Diabetes – Pipeline by Kriya Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Kyung Dong Co Ltd, 2021

Type 2 Diabetes – Pipeline by Laboratorios Silanes SA de CV, 2021

Type 2 Diabetes – Pipeline by Lannett Co Inc, 2021

Type 2 Diabetes – Pipeline by Lanzhou Institute of Biological Products Co Ltd, 2021

Type 2 Diabetes – Pipeline by Lead Discovery Center GmbH, 2021

Type 2 Diabetes – Pipeline by Lepu Medical Technology (Beijing) Co Ltd, 2021

Type 2 Diabetes – Pipeline by Levim Biotech LLP, 2021

Type 2 Diabetes – Pipeline by Lexicon Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by LG Chem Ltd, 2021

Type 2 Diabetes – Pipeline by Oncosimis Biotech Pvt Ltd, 2021

Type 2 Diabetes – Pipeline by OPKO Health Inc, 2021

Type 2 Diabetes – Pipeline by OptiKira LLC, 2021

Type 2 Diabetes – Pipeline by Oramed Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by Orbsen Therapeutics Ltd, 2021

Type 2 Diabetes – Pipeline by Original BioMedicals Co Ltd, 2021

Type 2 Diabetes – Pipeline by Palatin Technologies Inc, 2021

Type 2 Diabetes – Pipeline by Palisade Bio, Inc, 2021

Type 2 Diabetes – Pipeline by Panorama Researchama Research, 2021

Type 2 Diabetes – Pipeline by Paras Biopharmaceuticals Finland Oy, 2021

Type 2 Diabetes – Pipeline by Park Active Molecules, 2021

Type 2 Diabetes – Pipeline by PegBio Co Ltd, 2021

Type 2 Diabetes – Pipeline by Peptron Inc, 2021

Type 2 Diabetes – Pipeline by Pfizer Inc, 2021

Type 2 Diabetes – Pipeline by PharmaCyte Biotech Inc, 2021

Type 2 Diabetes – Pipeline by Pila Pharma AB, 2021

Type 2 Diabetes – Pipeline by Polus Inc, 2021

Type 2 Diabetes – Pipeline by Poxel SA, 2021

Type 2 Diabetes – Pipeline by Preveceutical Medical Inc, 2021

Type 2 Diabetes – Pipeline by ProLynx LLC, 2021

Type 2 Diabetes – Pipeline by Prometheon Pharma LLC, 2021

Type 2 Diabetes – Pipeline by Protheragen Inc, 2021

Type 2 Diabetes – Pipeline by Prous Institute for Biomedical Research SA, 2021

Type 2 Diabetes – Pipeline by Purzer Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Qoracle Co Ltd, 2021

Type 2 Diabetes – Pipeline by QuiaPEG Pharmaceuticals AB, 2021

Type 2 Diabetes – Pipeline by Rani Therapeutics LLC, 2021

Type 2 Diabetes – Pipeline by Rebio Technologies Ltd, 2021

Type 2 Diabetes – Pipeline by Regenerative Medical Solutions Inc, 2021

Type 2 Diabetes – Pipeline by Remd Biotherapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Remedium Bio Inc, 2021

Type 2 Diabetes – Pipeline by reMYND NV, 2021

Type 2 Diabetes – Pipeline by Renova Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Retinset SL, 2021

Type 2 Diabetes – Pipeline by Rezolute Inc, 2021

Type 2 Diabetes – Pipeline by Ridgeline Therapeutics LLC, 2021

Type 2 Diabetes – Pipeline by Rivus Pharmaceuticals Inc, 2021

Type 2 Diabetes – Pipeline by RosVivo Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Samik Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Samjin Pharm Co Ltd, 2021

Type 2 Diabetes – Pipeline by Sanofi, 2021

Type 2 Diabetes – Pipeline by Sanwa Kagaku Kenkyusho Co Ltd, 2021

Type 2 Diabetes – Pipeline by SBI Pharmaceuticals Co Ltd, 2021

Type 2 Diabetes – Pipeline by ScandiCure AB, 2021

Type 2 Diabetes – Pipeline by Sciwind Biosciences Co Ltd, 2021

Type 2 Diabetes – Pipeline by Scohia Pharma Inc, 2021

Type 2 Diabetes – Pipeline by Senseion Inc, 2021

Type 2 Diabetes – Pipeline by Sensulin LLC, 2021

Type 2 Diabetes – Pipeline by Seres Therapeutics Inc, 2021

Type 2 Diabetes – Pipeline by Serodus ASA, 2021

Type 2 Diabetes – Pipeline by Serpin Pharma LLC, 2021

Type 2 Diabetes – Pipeline by Shaanxi Micot Technology Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shandong Baijidichang Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shandong Luye Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shanghai Fosun Pharmaceutical (Group) Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shanghai HEP Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shanghai Innogen Pharmaceutical Technology Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shanghai Yingli Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shenzhen Salubris Pharmaceuticals Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shionogi & Co Ltd, 2021

Type 2 Diabetes – Pipeline by Shouyao Holding Co Ltd, 2021

Type 2 Diabetes – Pipeline by Sichuan Haisco Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Sihuan Pharmaceutical Holdings Group Ltd, 2021

Type 2 Diabetes – Pipeline by Sino Biopharmaceutical Ltd, 2021

Type 2 Diabetes – Pipeline by Sirona Biochem Corp, 2021

Type 2 Diabetes – Pipeline by SJT Molecular Research SL, 2021

Type 2 Diabetes – Pipeline by SK Chemicals Co Ltd, 2021

Type 2 Diabetes – Pipeline by Sosei Group Corp, 2021

Type 2 Diabetes – Pipeline by Stelis Biopharma Pvt Ltd, 2021

Type 2 Diabetes – Pipeline by Sulfateq BV, 2021

Type 2 Diabetes – Pipeline by Sun Pharmaceutical Industries Ltd, 2021

Type 2 Diabetes – Pipeline by Sveikatal Inc, 2021

Type 2 Diabetes – Pipeline by SymbioCellTech LLC, 2021

Type 2 Diabetes – Pipeline by Synokem Pharmaceuticals Ltd, 2021

Type 2 Diabetes – Pipeline by Taisho Pharmaceutical Holdings Co Ltd, 2021

Type 2 Diabetes – Pipeline by Takeda Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Techfields Pharma Co Ltd, 2021

Type 2 Diabetes – Pipeline by The Healthy Aging Co, 2021

Type 2 Diabetes – Pipeline by The United Laboratories International Holdings Ltd, 2021

Type 2 Diabetes – Pipeline by Theracos Inc, 2021

Type 2 Diabetes – Pipeline by Thermalin Inc, 2021

Type 2 Diabetes – Pipeline by Tonghua Dongbao Pharmaceutical Co Ltd, 2021

Type 2 Diabetes – Pipeline by Torrent Pharmaceuticals Ltd, 2021

Type 2 Diabetes – Dormant Projects, 2021

Type 2 Diabetes – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Type 2 Diabetes, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

Frequently Asked Questions

Enquire Before Buying
$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.